According to the new market research report "Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent Reference Laboratories, Hospital Laboratories) - Global Forecast to 2026", is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.
Browse in-depth TOC on "Esoteric Testing Market"
134 - Tables
47 - Figures
244 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708
Esoteric testing is a type of laboratory testing that focuses on rare and specialized tests. It often involves molecular, immunologic, and genetic testing, as well as an analysis of bodily fluids and tissues. Esoteric testing is used to diagnose conditions and diseases that may be difficult to detect with traditional laboratory tests.
The esoteric testing market is a rapidly growing industry that specializes in providing specialized and rare tests. Companies in this market often offer tests that are not available through traditional laboratory settings. These companies provide high-quality testing services that can be used to diagnose complex medical conditions.
Esoteric testing can be beneficial in a variety of ways. It can provide a more detailed diagnosis for complex medical conditions, allowing for more accurate treatment options to be pursued. It can also provide earlier detection of medical conditions, allowing for a better prognosis and earlier intervention. It can also identify rare genetic disorders and help to identify underlying causes of disease.
The future of the esoteric testing market looks bright. It is expected that the demand for more specialized tests will continue to grow, as hospitals and healthcare providers look for more accurate and effective ways to diagnose complex medical conditions. Additionally, advances in technology are expected to lead to more sophisticated tests, allowing for more accurate diagnoses.
Key Market Players:
The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708
This report categorizes the esoteric testing market into the following segments and subsegments:
By Type
- Infectious Diseases Testing
- Endocrinology Testing
- Oncology Testing
- Genetics Testing
- Toxicology Testing
- Immunology Testing
- Neurology Testing
- Other Testing
By Technology
- Chemiluminescence Immunoassay
- Enzyme-Linked Immunosorbent Assay
- Mass Spectrometry
- Real-Time PCR
- DNA Sequencing
- Flow Cytometry
- Other Technologies
By End User
- Independent Reference Laboratories
- Hospital-Based Laboratories
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Recent Developments
- Labcorp will acquire Myriad Genetics’ autoimmune business unit.
- Quest Diagnostics collaborated with GRAIL to support a first-of-its-kind multi-cancer early detection blood test called Galleri.
- OPKO Health Inc. (BioReference Laboratories) launched Scarlet Health, an in-home diagnostic, fully integrated digital platform, in the US.
- H.U. Group Holdings’ subsidiary, Miraca Holdings, partnered with the Chugai Pharmaceutical Co., Ltd.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=76794708
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
